New regulations from the VMD are streamlining the requirements for products seeking distribution through the AVM-GSL channel, focusing on clear product information for animal owners.
📍 United Kingdom
The Veterinary Medicines Directorate (VMD) has released updated guidance aimed at applicants seeking marketing authorisations or variations for products intended for distribution via the Authorised Veterinary Medicine – General Sales List (AVM-GSL). This list, which doesn’t require interaction between purchasers and veterinary professionals, highlights the importance of readily available product information to ensure animal owners select the most appropriate treatment. The new guidance provides clear specifications on what needs to be included on the product's outer packaging, including user-friendly language and standardized phrases designed for easy understanding at the point of sale.
This revised guidance is particularly crucial for companies transitioning products from categories like Non-Food Animal – Veterinarian, Pharmacist, SQP (NFA-VPS) to the AVM-GSL distribution level. It clarifies requirements for pack sizes, emphasizing that products authorized under a single marketing authorisation must adhere to these guidelines across all included sizes. The underlying principle remains consistent: as the distribution category decreases from prescription-only to general sales, the requirement for veterinary input diminishes, prioritizing accessible information for consumers.
Ultimately, the VMD’s goal is to ensure a smooth and transparent supply chain for AVM-GSL veterinary medicines, promoting responsible usage and safeguarding animal health. The full guidance can be found on the GOV.UK website, and queries can be directed to the VMD’s contact email for support.
Original Source: Link
#VeterinaryMedicine #AVMGSL #VMD #AnimalHealth #PetHealth #Pharmaceuticals #UKVeterinary #Regulation